English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Tumour-induced hypophosphatemic osteomalacia is often due to mesenchymal tumours. Surgical resection of tumour gives complete relief. We present the case of a 66-year-old male who sustained fracture of the hip after a trivial fall. After hip replacement surgery his proximal muscle weakness did not improve. On evaluation he had hypophosphatemia with hyperphosphaturia, raised fibroblast growth factor-23 levels. A gallium 68 (68Ga) - radiolabeled somatostatin analogue 1,4,7,10 – tetra azacyclododecane – N,N1, N11,N111 – tetraacetic acid (DOTA) 1-NaI3 – octreotide (NOC) positron emission tomography computed tomography revealed a somatosatin receptor avid polypoidal lesion in left posterior ethmoid sinus measuring 1.5 ˣ 1.6 cm likely representing mesenchymal tumour and retention cyst/polyp in left sphenoid sinus. Patient underwent a navigation assisted minimally invasive sinus surgery for removal of polypoidal lesion. Histopathological examination confirmed phosphaturic mesenchymal tumour.

Tumour-induced osteomalacia due to phosphaturic mesenchymal tumour of the ethmoid